ATE285770T1 - Verfahren zur herstellung von carbapenem- antibiotika zubereitungen - Google Patents
Verfahren zur herstellung von carbapenem- antibiotika zubereitungenInfo
- Publication number
- ATE285770T1 ATE285770T1 AT00974020T AT00974020T ATE285770T1 AT E285770 T1 ATE285770 T1 AT E285770T1 AT 00974020 T AT00974020 T AT 00974020T AT 00974020 T AT00974020 T AT 00974020T AT E285770 T1 ATE285770 T1 AT E285770T1
- Authority
- AT
- Austria
- Prior art keywords
- carbapenem
- carbapenem antibiotic
- antibiotic preparations
- producing carbapenem
- formulation
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 2
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- PLQZQEVQLGHUET-NUBCRITNSA-N C1C=CN2[C@H]1CC2=O.[Na] Chemical compound C1C=CN2[C@H]1CC2=O.[Na] PLQZQEVQLGHUET-NUBCRITNSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16248299P | 1999-10-29 | 1999-10-29 | |
| PCT/US2000/029869 WO2001032172A1 (en) | 1999-10-29 | 2000-10-27 | Process for formulation of carbapenem antibiotic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE285770T1 true ATE285770T1 (de) | 2005-01-15 |
Family
ID=22585803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00974020T ATE285770T1 (de) | 1999-10-29 | 2000-10-27 | Verfahren zur herstellung von carbapenem- antibiotika zubereitungen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1244444B1 (enExample) |
| JP (1) | JP4854899B2 (enExample) |
| AT (1) | ATE285770T1 (enExample) |
| AU (1) | AU770165B2 (enExample) |
| CA (1) | CA2388163C (enExample) |
| DE (1) | DE60017194T2 (enExample) |
| ES (1) | ES2234689T3 (enExample) |
| WO (1) | WO2001032172A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548492B1 (en) * | 1999-10-29 | 2003-04-15 | Merck & Co., Inc. | Process for formulation of carbapenem antibiotic compositions |
| JP2005522422A (ja) * | 2002-02-01 | 2005-07-28 | シモダ、バイオテック（プロプライエタリー）リミテッド | 医薬組成物 |
| EP2505191A1 (en) * | 2008-06-11 | 2012-10-03 | Ranbaxy Laboratories Limited | Lyophilized Carbapenem antibiotic composition |
| US8691803B2 (en) | 2011-01-24 | 2014-04-08 | Savior Lifetec Corporation | Process for the preparation of antibiotic compounds |
| US10016383B2 (en) | 2013-05-07 | 2018-07-10 | Mcmaster University | Inhibitors of metallo-β-lactamase-enzymes |
| KR101587420B1 (ko) * | 2014-08-20 | 2016-01-22 | 주식회사 대웅제약 | 에르타페넴-함유 동결건조제제의 제조방법 |
| KR20170014842A (ko) | 2015-07-31 | 2017-02-08 | 주식회사 대웅제약 | 개선된 에르타페넴 주사제의 제조방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP970281B1 (en) * | 1996-05-28 | 2002-04-30 | Merck & Co Inc | Carbapenem antibiotic, composition and method of preparation |
| UA62920C2 (en) * | 1996-05-28 | 2004-01-15 | Merck & Co Inc | Carbapeneme antibiotic, a composition and a method for the preparation |
| CA2268820A1 (en) * | 1996-10-28 | 1998-05-07 | Merck & Co., Inc. | Stabilized carbapenem antibiotic compositions and method of making |
| US6297231B1 (en) * | 1996-10-28 | 2001-10-02 | Merck & Co., Inc. | Stabilized carbapenem antibiotic compositions and method of making |
| JP3245427B2 (ja) * | 1997-06-16 | 2002-01-15 | メルク エンド カンパニー インコーポレーテッド | 安定化されたカルバペネム中間体および合成における使用 |
-
2000
- 2000-10-27 EP EP00974020A patent/EP1244444B1/en not_active Expired - Lifetime
- 2000-10-27 AU AU12456/01A patent/AU770165B2/en not_active Expired
- 2000-10-27 ES ES00974020T patent/ES2234689T3/es not_active Expired - Lifetime
- 2000-10-27 JP JP2001534377A patent/JP4854899B2/ja not_active Expired - Lifetime
- 2000-10-27 DE DE60017194T patent/DE60017194T2/de not_active Expired - Lifetime
- 2000-10-27 WO PCT/US2000/029869 patent/WO2001032172A1/en not_active Ceased
- 2000-10-27 AT AT00974020T patent/ATE285770T1/de not_active IP Right Cessation
- 2000-10-27 CA CA002388163A patent/CA2388163C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001032172A1 (en) | 2001-05-10 |
| CA2388163A1 (en) | 2001-05-10 |
| JP2003514779A (ja) | 2003-04-22 |
| EP1244444B1 (en) | 2004-12-29 |
| CA2388163C (en) | 2009-08-25 |
| AU1245601A (en) | 2001-05-14 |
| DE60017194T2 (de) | 2005-12-22 |
| DE60017194D1 (de) | 2005-02-03 |
| EP1244444A1 (en) | 2002-10-02 |
| JP4854899B2 (ja) | 2012-01-18 |
| AU770165B2 (en) | 2004-02-12 |
| ES2234689T3 (es) | 2005-07-01 |
| EP1244444A4 (en) | 2003-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE378341T1 (de) | Verfahren zur formulierung antibiotischer verbindungen | |
| HUT45247A (en) | Process for producing thiazolidinediones with hypolycaemic effect and pharmaceutical compositions comprising the same | |
| CA2030433A1 (en) | New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases | |
| HU9201258D0 (en) | Process for the production of medical preparations for treating hiv infections and of their active agents | |
| EP0649655A1 (en) | Injectable solutions containing anti-ulcer benzimidazoles and amides | |
| HUT67039A (en) | Process for preparing 2-substituted saccharin derivatives and pharmaceutical compositions containing them | |
| FI951468A0 (fi) | Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| KR910015562A (ko) | 뇌부전 질환치료용 약제, 신규 2-(1-피페라지닐)-4-페닐시클로알카노 피리미딘 유도체, 및 그의 제법 | |
| NO159592C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinderivater. | |
| ATE223916T1 (de) | Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung | |
| ES2132135T3 (es) | Procedimiento para la preparacion de compuestos de tiazolidina u oxazolidina farmaceuticamente activos mediante una reductasa de levadura. | |
| AU1732288A (en) | A process for the preparation of a solution of high concentration of a protein having tissue plasminogen activator (t-pa) activity, a solution containing protein having t-pa activity and the use of the solution in human and veterinary medicine | |
| ATE285770T1 (de) | Verfahren zur herstellung von carbapenem- antibiotika zubereitungen | |
| CA1214102A (en) | Pharmaceutical preparation containing purified fibronectin | |
| RU94042916A (ru) | 9a-n - (n'-карбамоил) - и 9a-n - (n'-тиокарбамоил) производные 9-деоксо- 9a - аза - 9a - гомоэтирмицина а, способ их получения и фармкомпозиция на их основе | |
| ATE100210T1 (de) | Lyophilisiertes mdm enthaltende zusammensetzung und verfahren zu deren herstellung. | |
| FI96424B (fi) | Menetelmä kiteisten kefeemihappoadditiosuolojen valmistamiseksi | |
| AU1022688A (en) | Antibacterial lyophilized preparation | |
| DE60127948D1 (de) | Verfahren zur herstellung von avermectinderivaten | |
| EP0153710A2 (en) | Novel toxoids of elastase of pseudomonas aeruginosa origin | |
| ATE335494T1 (de) | Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen | |
| WO2002060475A1 (en) | Methods for stabilizing lyophilized blood proteins | |
| RU94031260A (ru) | Питательная среда для выделения и культивирования гонококка | |
| ATE210985T1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen | |
| KR900014405A (ko) | 세팔로스포린 유도체 및 이의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |